BARCLAYS PLC - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 85 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$41
-60.6%
38,861
-3.8%
0.00%
Q2 2023$104
-41.9%
40,390
-8.4%
0.00%
Q1 2023$179
-48.9%
44,077
-36.9%
0.00%
Q4 2022$350
-99.9%
69,904
+59.3%
0.00%
-100.0%
Q3 2022$575,000
+76.4%
43,895
+72.6%
0.00%
Q2 2022$326,000
+10.5%
25,436
+31.3%
0.00%
Q1 2022$295,000
-85.1%
19,371
-82.6%
0.00%
Q4 2021$1,974,000
+190.7%
111,520
+245.7%
0.00%
Q3 2021$679,000
+452.0%
32,261
+420.2%
0.00%
Q2 2021$123,000
-84.1%
6,202
-76.7%
0.00%
Q1 2021$773,000
+57.1%
26,569
+63.6%
0.00%
Q4 2020$492,000
+21.8%
16,238
-36.1%
0.00%
Q3 2020$404,000
-10.2%
25,396
+11.2%
0.00%
Q2 2020$450,000
+63.0%
22,830
+2.0%
0.00%
Q1 2020$276,000
-65.5%
22,381
-48.3%
0.00%
Q4 2019$800,000
+99.5%
43,314
+49.8%
0.00%
Q3 2019$401,000
-6.3%
28,916
-1.3%
0.00%
Q2 2019$428,00029,2930.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$232,513,00049.48%
Ponoi II Management, LLC 1,298,908$16,652,00045.25%
Ponoi Management, LLC 1,298,908$16,652,00026.29%
Euclidean Capital LLC 746,674$9,572,0008.14%
StepStone Group LP 1,573,357$20,170,0002.16%
First Light Asset Management, LLC 1,135,884$14,562,0001.69%
Lexington Partners L.P. 110,428$1,416,0000.73%
Rubric Capital Management LP 797,588$10,225,0000.54%
Boxer Capital, LLC 500,000$6,410,0000.41%
DAFNA Capital Management LLC 107,653$1,380,0000.38%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders